GlassScriptPhysician profile
Matt N Young
NPI 1043260458
$2,756.95
in general payments reported to CMS, 2019-2025
22 companies · $26.42 in 2025
The $26.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $137 · 2021: $916 · 2022: $395 · 2023: $466 · 2024: $48.20 · 2025: $26.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $643.96 | 2019-2023 | Grafix, Renasys Go V2 Home, Pico |
| Stryker Corporation | $575.98 | 2019-2023 | T2 |
| Zimmer Biomet Holdings, INC. | $415.53 | 2021 | |
| Integra Lifesciences Corporation | $184.33 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Next Science LLC | $165.30 | 2023 | Xperience, Blastx, Surgx |
| Convatec INC. | $127.04 | 2020-2023 | |
| Bone Support INC. | $115.66 | 2022 | |
| Misonix INC | $64.78 | 2019-2021 | |
| Acera Surgical, INC. | $59.01 | 2022-2025 | Restrata Wound Matrix |
| Osiris Therapeutics INC. | $58.94 | 2019 | |
| Kerecis Limited | $47.65 | 2021 | |
| Aroa Biosurgery Incorporated | $45.25 | 2023-2024 | |
| Avita Medical Americas, LLC | $41.58 | 2019 | |
| Solventum Corporation | $27.82 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, V.A.C.Instill |
| Organogenesis INC. | $27.59 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $25.71 | 2021 | |
| Innovation Technologies INC | $24.95 | 2021 | |
| Kci USA, INC. | $24.30 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Allergan, INC. | $21.69 | 2020 | |
| Paratek Pharmaceuticals, INC. | $21.24 | 2023 | Nuzyra |
| Acell, INC. | $21.13 | 2020 | |
| Biotissue Holdings INC. | $17.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.